Capital expenditure increased 240.8%
Capital expenditure changed +240.8% from the comparable as-filed period.
$3.9M→$13.4M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MSCI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue increased 12.4%
Revenue changed +12.4% from the comparable as-filed period.
$793.4M→$892.0M2 prior comparisons
Gross debt increased 22.0%
Gross debt changed +22.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$5.5B→$6.7B4 prior comparisons
Reported total debt increased 22.0%
Reported total debt changed +22.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$5.5B→$6.7B4 prior comparisons
Noncurrent long-term debt increased 22.0%
Noncurrent long-term debt changed +22.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$5.5B→$6.7B4 prior comparisons
Debt / assets moved 1784 bp higher
Debt / assets changed +1784 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
102.20%→120.05%4 prior comparisons
Free-cash-flow proxy decreased 5.1%
Free-cash-flow proxy changed -5.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$445.5M→$422.7M2 prior comparisons
Operating cash-flow margin moved 776 bp lower
Operating cash-flow margin changed -776 basis points from the comparable as-filed period.
56.65%→48.89%2 prior comparisons
Free-cash-flow margin moved 876 bp lower
Free-cash-flow margin changed -876 basis points from the comparable as-filed period.
56.15%→47.39%2 prior comparisons
Debt / revenue moved 5884 bp higher
Debt / revenue changed +5884 basis points from the comparable as-filed period.
694.18%→753.02%2 prior comparisons
Operating cash flow decreased 3.0%
Operating cash flow changed -3.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$449.4M→$436.1M2 prior comparisons
Capex / revenue moved 101 bp higher
Capex / revenue changed +101 basis points from the comparable as-filed period.
0.50%→1.50%2 prior comparisons
Stock-based compensation increased 21.8%
Stock-based compensation changed +21.8% from the comparable as-filed period.
$22.6M→$27.5M2 prior comparisons
Operating margin moved 14 bp lower
Operating margin changed -14 basis points from the comparable as-filed period.
56.42%→56.29%2 prior comparisons
Working capital / assets moved 168 bp lower
Working capital / assets changed -168 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
-3.26%→-4.93%4 prior comparisons
Current liabilities increased 6.1%
Current liabilities changed +6.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.5B→$1.6B4 prior comparisons
Shares outstanding decreased 4.8%
Shares outstanding changed -4.8% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
75,139,539→71,500,0008 prior comparisons
Total assets increased 3.8%
Total assets changed +3.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$5.4B→$5.6B4 prior comparisons
Research & development increased 6.2%
Research & development changed +6.2% from the comparable as-filed period.
$44.8M→$47.6M2 prior comparisons
SBC / revenue moved 24 bp higher
SBC / revenue changed +24 basis points from the comparable as-filed period.
2.85%→3.08%2 prior comparisons
Current ratio decreased 6.5%
Current ratio changed -6.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
0.88→0.824 prior comparisons
Current assets decreased 0.8%
Current assets changed -0.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$1.3B→$1.3B4 prior comparisons
R&D / revenue moved 31 bp lower
R&D / revenue changed -31 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
5.65%→5.34%2 prior comparisons
Revenue increased 12.2%
Revenue changed +12.2% from the comparable as-filed period.
$772.7M→$867.0M2 prior comparisons
Operating margin moved 119 bp higher
Operating margin changed +119 basis points from the comparable as-filed period.
55.03%→56.23%2 prior comparisons
Free-cash-flow proxy increased 10.8%
Free-cash-flow proxy changed +10.8% from the comparable as-filed period.
$324.7M→$359.8M3 prior comparisons
Operating cash flow increased 10.3%
Operating cash flow changed +10.3% from the comparable as-filed period.
$336.1M→$370.8M3 prior comparisons
Total assets increased 4.3%
Total assets changed +4.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$5.4B→$5.6B4 prior comparisons
Debt / revenue moved 15184 bp higher
Debt / revenue changed +15184 basis points from the comparable as-filed period.
584.08%→735.92%2 prior comparisons
Current liabilities increased 9.2%
Current liabilities changed +9.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.5B→$1.6B4 prior comparisons
Working capital increased 14.8%
Working capital changed +14.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
-$199.0M→-$169.5M4 prior comparisons
Capex / revenue moved 21 bp lower
Capex / revenue changed -21 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.48%→1.27%2 prior comparisons
Cash & equivalents increased 2.6%
Cash & equivalents changed +2.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$347.3M→$356.4M4 prior comparisons
SBC / revenue moved 7 bp lower
SBC / revenue changed -7 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
3.00%→2.93%2 prior comparisons
Research & development increased 4.4%
Research & development changed +4.4% from the comparable as-filed period.
$44.1M→$46.0M2 prior comparisons
Stock-based compensation increased 9.6%
Stock-based compensation changed +9.6% from the comparable as-filed period.
$23.2M→$25.4M3 prior comparisons
Working capital / assets moved 68 bp higher
Working capital / assets changed +68 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
-3.70%→-3.03%4 prior comparisons
R&D / revenue moved 40 bp lower
R&D / revenue changed -40 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
5.70%→5.31%2 prior comparisons
Operating cash-flow margin moved 73 bp lower
Operating cash-flow margin changed -73 basis points from the comparable as-filed period.
43.50%→42.77%2 prior comparisons
Current ratio increased 3.4%
Current ratio changed +3.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
0.86→0.894 prior comparisons
Free-cash-flow margin moved 52 bp lower
Free-cash-flow margin changed -52 basis points from the comparable as-filed period.
42.02%→41.50%2 prior comparisons
Capital expenditure decreased 3.9%
Capital expenditure changed -3.9% from the comparable as-filed period.
$11.4M→$11.0M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.